MEI Pharma has announced a $100 million private investment at $3.42 per share, marking a bold step forward in its growth strategy. As part of the deal, Charlie Lee, creator of Litecoin, will join MEI’s Board of Directors, replacing Taheer Datoo.
MEI has also appointed GSR as its digital asset and treasury advisor to help launch its new Litecoin Treasury Strategy, with a unique blend of biotech and blockchain.
First Public Company to Adopt LTC as Reserve
The $100M funding round was also backed by the Litecoin Foundation and top crypto firms like…